P2X7 receptor antagonists (Hoffmann-La Roche)

N/A

Report date: 2025/03/20 10:02:53
NME

Base Information

Drug NameP2X7 receptor antagonists (Hoffmann-La Roche)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2X purinoceptor 7 antagonists
TargetsP2X purinoceptor 7
Therapy Area/IndicationsInflammationImmune System DiseasesNervous System Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHoffmann-La Roche Inc
China Registration ClassN/A

Develop Information

Active CompaniesHoffmann-La Roche Inc
Inactive CompaniesN/A
Active IndicationsInflammationImmune System DiseasesNervous System Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A